Abstract:An extract prepared from the culture of a marine-derived actinomycete Streptomyces sp. ZZ338 was found to have significant antimicrobial and antiproliferative activities. A chemical investigation of this active extract resulted in the isolation of three known bioactive actinomycins (1-3) and two new metabolites (4 and 5). The structures of the isolated compounds were identified as actinomycins D (1), V (2), X0β (3), 2-acetylamino-3-hydroxyl-4-methyl-benzoic acid methyl ester (4), and N-1S-(4-methylaminophenylmethyl)-2-oxo-propyl acetamide (5) based on their nuclear magnetic resonance (NMR) and high resolution electrospray ionization mass spectroscopy (HRESIMS) data as well as their optical rotation. This class of new compound 5 had never before been found from a natural resource. Three known actinomycins showed activities in inhibiting the proliferation of glioma cells and the growth of methicillin-resistant Staphylococcus aureus, Escherichia coli, and Candida albicans and are responsible for the activity of the crude extract. Actinomycin D (1) was also found to downregulate several glioma metabolic enzymes of glycolysis, glutaminolysis, and lipogenesis, suggesting that targeting multiple tumor metabolic regulators might be a new anti-glioma mechanism of actinomycin D. This is the first report of such a possible mechanism for the class of actinomycins.

A New Medermycin Analog from the Marine-Derived Actinomycetes Streptomyces Sp. ZS-A45.

A New Compound from the Marine-Derived Streptomyces Sp. SS13M

Derivatives of Holomycin and Cyclopropaneacetic Acid from Streptomyces Sp Dt-A37

Medermycin-Type Naphthoquinones from the Marine-Derived Streptomyces Sp XMA39

Two New P-Methoxyphenyl-type Derivatives from a Saline-Lake Derived Streptomyces Sp. XZB32.

Bioactive Metabolites from Marine-Derived Streptomyces Sp A68 and Its Rifampicin Resistant Mutant Strain R-M1

Cytotoxic Metabolites from the Marine-Associated Streptomyces Sp. ZZ1944

MDN-0171, a new medermycin analogue from Streptomyces albolongus CA-186053

Cytotoxic and Antifungal Staurosporine Derivatives from Marine-Derived Actinomycete Streptomyces Sp. ZS-A121

Cytotoxic Bafilomycin Analogues 6/5/5 with Tricyclic Ring System from a Marine-Derived Streptomyces Sp

Strepolyketide D, a New SEK15-derived Polyketide Compound from Salt-Lake-derived Streptomyces Sp. DBC5.

New Antifungal Metabolites from the Mariana Trench Sediment-Associated Actinomycete Streptomyces Sp. SY1965

Purmedermycins A and B, Two Novel Medermycin Derivatives from Streptomyces Sp. SS17A

Lactoquinomycin C and D, Two New Medermycin Derivatives from the Marine-Derived Streptomyces Sp. SS17A

Streptonaphthyridine A, a New Naphthyridine Analogue with Antiproliferative Activity Against Human Glioma Cells from Mariana Trench-Associated Actinomycete Streptomyces Sp. SY2111

New Metabolites and Bioactive Actinomycins from Marine-Derived Streptomyces sp. ZZ338

A Unique Indolizinium Alkaloid Streptopertusacin A and Bioactive Bafilomycins from Marine-Derived Streptomyces Sp. HZP-2216E.

Suncheonosides E-M and Benzothioate Derivatives from the Marine-Derived Streptomyces sp. ZSN77

Streptoindoles A–D, Novel Antimicrobial Indole Alkaloids from the Marine-Associated Actinomycete Streptomyces Sp. ZZ1118

A New Antibacterial 3,5-Dimethylorsellinic Acid-Based Meroterpene from the Marine Fungus Aspergillus Sp. CSYZ-1.

New Antibacterial Bagremycins F and G from the Marine-Derived Streptomyces Sp. ZZ745